Your browser doesn't support javascript.
loading
The Experiences of Drug List Formulation Procedure Based on Pharmaeconomics and the Enlightenment to China / 中国卫生经济
Chinese Health Economics ; (12): 94-96, 2018.
Artículo en Chino | WPRIM | ID: wpr-703518
ABSTRACT

Objectives:

To analyze the role of pharmaeconomics during drug list formulation procedure and the enlightenment to China.

Methods:

Using literature review and comparative analysis method, it compared the drug list formulation procedure of WHO, Australia, UK, Tailand and the role of pharmaeconomics.

Results:

Using pharmaeconomics method was common in international experience. The methodology of pharmaeconomics was also well developed.

Conclusions:

To improve China drug selection procedure, China should enhance government policy invest in pharmaeconomics usage and support the research, break down the grey benefit relation between medicine and medical.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Health Economics Año: 2018 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Chinese Health Economics Año: 2018 Tipo del documento: Artículo